WATSON 152 8 mg (Rapaflo 8 mg)
Generic Name: silodosin
Pill imprint WATSON 152 8 mg has been identified as Rapaflo 8 mg.
Rapaflo is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Rapaflo 8 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 8 mg
- 19.00 mm
- Prescription only
More about Rapaflo (silodosin)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.